Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
M3 ( (JP:2413) ) has issued an update.
M3, Inc. reported a significant decline in its non-consolidated financial results for the fiscal year ending March 31, 2025, compared to the previous year. The company experienced decreases in net sales and operating profit due to reduced pharmaceutical marketing budgets and the waning impact of COVID-19 projects. Additionally, ordinary profit and profit were further impacted by the absence of dividend income from subsidiaries, although this did not affect the consolidated financial results.
More about M3
M3, Inc. operates in the healthcare industry, focusing on pharmaceutical marketing support and related services. The company is listed on the Tokyo Stock Exchange and is headquartered in Tokyo, Japan.
YTD Price Performance: 9.25%
Average Trading Volume: 100
Technical Sentiment Signal: Buy
Current Market Cap: $8.47B
For a thorough assessment of 2413 stock, go to TipRanks’ Stock Analysis page.